Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells (Q56967600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Herbert Kim Lyerly

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Michael Morse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

David Boczkowski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Eli Gilboa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Smita K Nair

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Ian Cumming

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

number of pages

10

1 reference

inferred from page(s)

published in

Annals of Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

540-549

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11923611%20AND%20SRC:MED&resulttype=core&format=json

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

8 December 2019

cites work

1 reference

12 December 2020

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

12 December 2020

Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides

1 reference

12 December 2020

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

12 December 2020

New opportunities for the development of cancer immunotherapies

1 reference

12 December 2020

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

12 December 2020

Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials

1 reference

12 December 2020

Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine

1 reference

12 December 2020

Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.

1 reference

12 December 2020

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

12 December 2020

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

1 reference

12 December 2020

Tumour immunotherapy: the adjuvant treatment of the 21st century?

1 reference

12 December 2020

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

1 reference

12 December 2020

A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity

1 reference

12 December 2020

Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma

1 reference

12 December 2020

Green fluorescent protein as a marker for gene expression

1 reference

12 December 2020

Proliferating dendritic cell progenitors in human blood

1 reference

12 December 2020

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

12 December 2020

Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.

1 reference

12 December 2020

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

12 December 2020

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

12 December 2020

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

12 December 2020

Induction of antitumor immunity using bone marrow-generated dendritic cells

1 reference

12 December 2020

Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma.

1 reference

12 December 2020

Antigen processing and presentation by the class I major histocompatibility complex

1 reference

12 December 2020

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.

1 reference

12 December 2020